Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers.

The influences of 1-ethyl-, 1-butyl-, 1-hexyl-, and 1-octyl-2-pyrrolidone in their saline solutions on the transport of beta-estradiol, corticosterone, and hydrocortisone across hairless mouse skin under in vitro conditions have been investigated by the physical model approach. The experimental data were interpreted with a physical model that treats the stratum corneum as a diffusional barrier with a lipoidal pathway and a pore pathway. Enhancement factors (E values) for the lipoidal pathway were calculated from the permeability coefficients and solubility data as a function of the 1-alkyl-2-pyrrolidone concentration for all three permeants. A pattern of increasing E values with increasing 1-alkyl-2-pyrrolidone chain length was found, and the results were essentially the same for all three steroidal permeants. A nearly semilogarithmic linear relationship was also obtained between the enhancement potency and the carbon number of the alkyl chain; there was about an approximately 3.5-fold increase in the enhancement potency per 1-alkyl-2-pyrrolidone methylene group. An important outcome of this research is that the enhancement potencies of the 1-alkyl-2-pyrrolidones were essentially the same as those for the previously studied n-alkanols when compared at the same carbon numbers of the alkyl groups. This result is somewhat surprising as it suggests that the enhancer action resides (in its entirety) in the alkyl group, and the nature of the polar head group may not be intrinsically important in transdermal enhancement of the lipoidal pathway within a class of permeation enhancers.

[1]  T. Xiang,et al.  Substituent contributions to the transport of substituted p-toluic acids across lipid bilayer membranes. , 1994, Journal of pharmaceutical sciences.

[2]  T. Xiang,et al.  Molecular distributions in interphases: statistical mechanical theory combined with molecular dynamics simulation of a model lipid bilayer. , 1994, Biophysical journal.

[3]  J. Fox,et al.  The effects of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. A new quantitative approach☆ , 1987 .

[4]  J. Fox,et al.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate II: Parameter determinations. , 1979, Journal of pharmaceutical sciences.

[5]  W. Deen Hindered transport of large molecules in liquid‐filled pores , 1987 .

[6]  Y. H. Kim,et al.  Fluorescence anisotropy studies on the interaction of the short chain n-alkanols with stratum corneum lipid liposomes (SCLL) and distearoylphosphatidylcholine (DSPC)/distearoylphosphatidic acid (DSPA) liposomes. , 1993, Biochimica et biophysica acta.

[7]  B. W. Barry,et al.  Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin , 1987, The Journal of pharmacy and pharmacology.

[8]  H. Sasaki,et al.  Enhancing effect of pyrrolidone derivatives on transdermal drug delivery. I. , 1988 .

[9]  T. Xiang,et al.  Transport methods for probing the barrier domain of lipid bilayer membranes. , 1992, Biophysical journal.

[10]  H. Sasaki,et al.  Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen. , 1991, Journal of pharmaceutical sciences.

[11]  A. Ghanem,et al.  The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a novel approach , 1992 .

[12]  K. Sugibayashi,et al.  Effect of several penetration enhancers on the percutaneous absorption of indomethacin in hairless rats. , 1988, Chemical & pharmaceutical bulletin.

[13]  H. Sasaki,et al.  Enhancing effect of pyrrolidone derivatives on transdermal drug delivery II. Effect of application concentration and pre-treatment of enhancer , 1990 .

[14]  Yong-Hee Kim,et al.  Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: Mechanism(s) of action , 1992 .

[15]  W. Deen,et al.  Effects of molecular size and configuration on diffusion in microporous membranes , 1981 .